4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-028811
EVP, Research & CSO sold 7,900 shares at $49.50 ($391,077)
- EVP, Research & CSO acquired 7,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-04-27 | Option exercise | +7,900 | $1.53 | $12,087 | 99,600 | D |
| Virgin Herbert EVP, Research & CSO | 2021-04-27 | Sale | −7,900 | $49.50 | $391,077 | 91,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2021-04-27 | Option exercise · Stock Option (Right to Buy) | −7,900 | 304,255 | D | ||
| Open-market sales · 7,900 sh · avg $49.50 · $391,077 | |||||||
Loading xslF345X03/doc4.xml…